• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声乳化术中经巩膜睫状体给药莫西沙星和地塞米松:一种新的无滴剂方案。

Transzonular moxifloxacin and dexamethasone delivery in phacoemulsification: A novel dropless regimen.

机构信息

Institute of Ophthalmology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

出版信息

Indian J Ophthalmol. 2024 Aug 1;72(8):1147-1149. doi: 10.4103/IJO.IJO_2697_23. Epub 2024 May 20.

DOI:10.4103/IJO.IJO_2697_23
PMID:38767558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11451781/
Abstract

PURPOSE

To assess the safety and efficacy of transzonular moxifloxacin and dexamethasone versus standard postoperative topical drug regimen in phacoemulsification.

DESIGN

Nonrandomized prospective study.

METHODS

The study included 100 eyes of 100 age and gender-matched individuals with senile cataract undergoing routine phacoemulsification. The patients were consecutively divided into transzonular (TZ = 50) and topical (TP = 50) groups. Both the groups were followed up for 4 weeks and assessed for intraocular inflammation, visual acuity, changes in intraocular pressure (IOP), and any adverse events.

RESULTS

The grades of inflammation were significantly lower in TZ as compared to the TP group ( P < 0.001). The IOP remained normal and comparable in both the groups. Most of the patients in the two groups attained a visual acuity of 0.2 or better at the end of the follow-up. No adverse effects and increased rate of endophthalmitis were noted in TZ group.

CONCLUSION

A one-time peroperative TZ moxifloxacin and dexamethasone combination is a safe and effective method to control postoperative inflammation after cataract surgery. A word of caution though, due precautions to be exercised to prevent the risk of inflammation and endophthalmitis.

摘要

目的

评估经巩膜莫西沙星和地塞米松与白内障超声乳化术后标准局部药物治疗方案的安全性和有效性。

设计

非随机前瞻性研究。

方法

本研究纳入了 100 例年龄和性别匹配的老年性白内障患者的 100 只眼,均行常规超声乳化白内障吸除术。患者连续分为经巩膜(TZ=50)和局部(TP=50)两组。两组均随访 4 周,评估眼内炎症、视力、眼压(IOP)变化及任何不良事件。

结果

TZ 组的炎症分级明显低于 TP 组(P<0.001)。两组的 IOP 均保持正常且相似。两组患者在随访结束时大多达到 0.2 或更好的视力。TZ 组未出现不良反应和眼内炎发生率增加。

结论

白内障术后单次经巩膜莫西沙星和地塞米松联合应用是控制术后炎症的一种安全有效的方法。但需注意,应谨慎操作以预防炎症和眼内炎的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d88/11451781/fa5884b86b6e/IJO-72-1147-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d88/11451781/8ba6758503f0/IJO-72-1147-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d88/11451781/f47b6fd3c101/IJO-72-1147-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d88/11451781/fa5884b86b6e/IJO-72-1147-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d88/11451781/8ba6758503f0/IJO-72-1147-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d88/11451781/f47b6fd3c101/IJO-72-1147-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d88/11451781/fa5884b86b6e/IJO-72-1147-g003.jpg

相似文献

1
Transzonular moxifloxacin and dexamethasone delivery in phacoemulsification: A novel dropless regimen.超声乳化术中经巩膜睫状体给药莫西沙星和地塞米松:一种新的无滴剂方案。
Indian J Ophthalmol. 2024 Aug 1;72(8):1147-1149. doi: 10.4103/IJO.IJO_2697_23. Epub 2024 May 20.
2
Intracameral moxifloxacin after cataract surgery: a prospective study.白内障手术后前房内注射莫西沙星:一项前瞻性研究。
Arq Bras Oftalmol. 2018 Apr;81(2):92-94. doi: 10.5935/0004-2749.20180022.
3
Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial.眼内注射莫西沙星预防白内障术后眼内炎的安全性和有效性:随机对照临床试验。
J Cataract Refract Surg. 2019 Mar;45(3):343-350. doi: 10.1016/j.jcrs.2018.10.044. Epub 2019 Jan 25.
4
Acute-onset postoperative endophthalmitis after cataract surgery and transzonular intravitreal triamcinolone-moxifloxacin.白内障手术后和经巩膜睫状体光凝术玻璃体内注射曲安奈德-莫西沙星后急性发作的眼内炎。
J Cataract Refract Surg. 2018 Dec;44(12):1436-1440. doi: 10.1016/j.jcrs.2018.07.055. Epub 2018 Sep 18.
5
Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery.白内障手术中未稀释前房内注射莫西沙星且术后不使用局部抗生素的安全性
Int Ophthalmol. 2016 Aug;36(4):493-8. doi: 10.1007/s10792-015-0151-x. Epub 2015 Nov 14.
6
Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study.用于白内障手术相关炎症的 IBI-10090 的安全性:3 期多中心研究。
J Cataract Refract Surg. 2018 Oct;44(10):1236-1246. doi: 10.1016/j.jcrs.2018.07.015. Epub 2018 Aug 20.
7
Transzonular Triamcinolone-Moxifloxacin Versus Topical Drops for the Prophylaxis of Postoperative Inflammation After Cataract Surgery.经晶状体囊膜曲安奈德-莫西沙星与局部滴眼液预防白内障手术后炎症的比较
J Ocul Pharmacol Ther. 2019 Dec;35(10):565-570. doi: 10.1089/jop.2019.0097. Epub 2019 Oct 15.
8
Efficacy and safety of dropless cataract surgery.无灌流白内障手术的疗效和安全性。
Indian J Ophthalmol. 2020 Jun;68(6):1081-1085. doi: 10.4103/ijo.IJO_1186_19.
9
[Minimally inflammatory cataract surgery].[微创炎性白内障手术]
Klin Monbl Augenheilkd. 1996 Dec;209(6):331-9. doi: 10.1055/s-2008-1035330.
10
Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery.白内障手术后预防眼内炎症和黄斑水肿的单次眼周皮质类固醇储库与术后皮质类固醇眼药水的比较。
J Cataract Refract Surg. 2011 Sep;37(9):1589-97. doi: 10.1016/j.jcrs.2011.03.049.

本文引用的文献

1
Transzonular Triamcinolone-Moxifloxacin Versus Topical Drops for the Prophylaxis of Postoperative Inflammation After Cataract Surgery.经晶状体囊膜曲安奈德-莫西沙星与局部滴眼液预防白内障手术后炎症的比较
J Ocul Pharmacol Ther. 2019 Dec;35(10):565-570. doi: 10.1089/jop.2019.0097. Epub 2019 Oct 15.
2
Comparative analysis of intravitreal triamcinolone acetonide-moxifloxacin versus standard perioperative eyedrops in cataract surgery.白内障手术中玻璃体内曲安奈德-莫西沙星与标准围手术期滴眼剂的比较分析。
J Cataract Refract Surg. 2019 Jun;45(6):760-765. doi: 10.1016/j.jcrs.2018.12.019. Epub 2019 Mar 6.
3
Dropless Cataract Surgery: An Overview.
无灌注白内障手术概述
Curr Pharm Des. 2017;23(4):558-564. doi: 10.2174/1381612822666161129150628.
4
Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review.白内障手术后注射复方制剂进行预防的临床结局:一项大规模综述。
Curr Opin Ophthalmol. 2017 Jan;28(1):73-80. doi: 10.1097/ICU.0000000000000329.
5
Transzonular vitreous injection vs a single drop compounded topical pharmaceutical regimen after cataract surgery.白内障手术后经睫状体平坦部玻璃体注射与单滴复方局部用药方案的比较
Clin Ophthalmol. 2016 Jul 18;10:1297-303. doi: 10.2147/OPTH.S112080. eCollection 2016.
6
Evaluation of eyedrop administration by inexperienced patients after cataract surgery.白内障手术后无经验患者滴眼剂给药情况的评估。
J Cataract Refract Surg. 2014 Nov;40(11):1857-61. doi: 10.1016/j.jcrs.2014.02.037. Epub 2014 Sep 22.
7
Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery.白内障超声乳化手术结束时前房内注射地塞米松与前房内注射曲安奈德的比较。
Indian J Ophthalmol. 2014 Aug;62(8):861-4. doi: 10.4103/0301-4738.141045.
8
Effects of intracameral triamcinolone and gentamicin injections following cataract surgery.白内障手术后前房注射曲安奈德和庆大霉素的效果。
J Med Assoc Thai. 2011 Jul;94(7):819-25.
9
Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma.前房内注射地塞米松可减轻白内障手术后第一天有或没有青光眼的眼睛的炎症。
Clin Ophthalmol. 2009;3:345-55. doi: 10.2147/opth.s5730. Epub 2009 Jun 2.
10
Effect of intracameral triamcinolone to control inflammation following cataract surgery.前房内注射曲安奈德对控制白内障手术后炎症的作用。
J Cataract Refract Surg. 2005 Aug;31(8):1670-1. doi: 10.1016/j.jcrs.2005.07.023.